Company Details
Rivermark Medical
Overview
Minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH).
Total Raised
$50 M
Rounds
2
Links
Verticals
Health Care
Hospital
Medical Device
Investment History
Series D
May 2026
$20M
Series C
Oct 2024
$30M